-
1
-
-
34748841969
-
Combination therapy with non-clozapine atypical antipsychotic medication: A review of current evidence
-
DOI 10.1177/0269881106071334
-
Chan J, Sweeting M. Review: combination therapy with non-clozapine atypical antipsychotic medication: a review of current evidence. J Psychopharmacol. 2007;21(6):657-664. (Pubitemid 47472722)
-
(2007)
Journal of Psychopharmacology
, vol.21
, Issue.6
, pp. 657-664
-
-
Chan, J.1
Sweeting, M.2
-
2
-
-
0037407492
-
Aripiprazole: Does partial dopaminergic agonism translate into clinical benefits?
-
DOI 10.1345/aph.1D014
-
Crismon ML, DeLeon A, Miller AL. Aripiprazole: does partial dopaminergic agonism translate into clinical benefits? Ann Pharmacother. 2003;37:738-740. (Pubitemid 36523072)
-
(2003)
Annals of Pharmacotherapy
, vol.37
, Issue.5
, pp. 738-740
-
-
Crismon, M.L.1
DeLeon, A.2
Miller, A.L.3
-
3
-
-
45249113944
-
Aripiprazole augmentation in clozapine-treated patients with refractory schizophrenia: An 8-week, randomized, double-blind, placebo-controlled trial
-
Chang JS, Ahn YM, Park HJ, et al. Aripiprazole augmentation in clozapine-treated patients with refractory schizophrenia: an 8 week, randomized, double-blind, placebo-controlled trial. J Clin Psychiatry. 2008;69(5): 720-731. (Pubitemid 351838681)
-
(2008)
Journal of Clinical Psychiatry
, vol.69
, Issue.5
, pp. 720-731
-
-
Chang, J.S.1
Ahn, Y.M.2
Park, H.J.3
Lee, K.Y.4
Kim, S.H.5
Kang, U.G.6
Kim, Y.S.7
-
5
-
-
33751119908
-
Clozapine augmented with aripiprazole in 5 patients with schizophrenia [4]
-
DOI 10.1097/01.jcp.0000246206.65411.f5, PII 0000471420061200000023
-
Abu-Tair F, Kopitz J, Bergemann N. Clozapine augmented with aripiprazole in 5 patients with schizophrenia. J Clin Psychopharmacol. 2006;26(6):669-671. (Pubitemid 44772751)
-
(2006)
Journal of Clinical Psychopharmacology
, vol.26
, Issue.6
, pp. 669-671
-
-
Abu-Tair, F.1
Kopitz, J.2
Bergemann, N.3
-
7
-
-
1442332132
-
Worsened agitation with aripiprazole: Adverse effect of dopamine partial agonism?
-
DeQuardo JR. Worsened agitation with aripiprazole: adverse effect of dopamine partial agonism? J Clin Psychiatry. 2004;65(1):132-133.
-
(2004)
J Clin Psychiatry.
, vol.65
, Issue.1
, pp. 132-133
-
-
Dequardo, J.R.1
-
8
-
-
3042699593
-
Worsening schizoaffective disorder with aripiprazole
-
Reeves RR, Mack JE. Worsening schizoaffective disorder with aripiprazole. Am J Psychiatry. 2004;161(7):1308.
-
(2004)
Am J Psychiatry.
, vol.161
, Issue.7
, pp. 1308
-
-
Reeves, R.R.1
MacK, J.E.2
-
9
-
-
34249714698
-
Aripiprazole and worsening of psychosis: A case report [9]
-
Ahuja N, Lloyd AJ. Aripiprazole and worsening of psychosis: a case report. J Clin Psychiatry. 2007;68(5): 805-806. (Pubitemid 46841875)
-
(2007)
Journal of Clinical Psychiatry
, vol.68
, Issue.5
, pp. 805-806
-
-
Ahuja, N.1
Lloyd, A.J.2
-
10
-
-
1642452858
-
Aripiprazole possibly worsens psychosis
-
DOI 10.1097/00004850-200401000-00009
-
Ramaswamy S, Vijad D, William M, et al. Aripiprazole possibly worsens psychosis. Int Clin Psychopharmacol. 2004;19(1):45-48. (Pubitemid 38114625)
-
(2004)
International Clinical Psychopharmacology
, vol.19
, Issue.1
, pp. 45-48
-
-
Ramaswamy, S.1
Vijay, D.2
William, M.3
Sattar, S.P.4
Praveen, F.5
Petty, F.6
-
11
-
-
61349197541
-
Aripiprazole in combination with other antipsychotic drugs may worsen psychosis
-
Adan-Manes J, Garcia-Parajua P. Aripiprazole in combination with other antipsychotic drugs may worsen psychosis. J Clin Pharm Ther. 2009;34(2):245-246.
-
(2009)
J Clin Pharm Ther.
, vol.34
, Issue.2
, pp. 245-246
-
-
Adan-Manes, J.1
Garcia-Parajua, P.2
-
12
-
-
72849140996
-
A multicenter, randomized, double-blind, placebo-controlled, 16-week study of adjunctive aripiprazole for schizophrenia or schizoaffective disorder inadequately treated with quetiapine or risperidone monotherapy
-
Kane JM, Correll CU, Goff DC, et al. A multicenter, randomized, double-blind, placebo-controlled, 16-week study of adjunctive aripiprazole for schizophrenia or schizoaffective disorder inadequately treated with quetiapine or risperidone monotherapy. J Clin Psychiatry. 2009;70(10):1348-1357.
-
(2009)
J Clin Psychiatry.
, vol.70
, Issue.10
, pp. 1348-1357
-
-
Kane, J.M.1
Correll, C.U.2
Goff, D.C.3
-
13
-
-
77957230409
-
Effects of adjunctive treatment with aripiprazole on body weight and clinical efficacy in schizophrenia patients treated with clozapine: A randomized, double-blind, placebo-controlled trial
-
Fleischhacker WW, Heikkinen ME, Olié JP, et al. Effects of adjunctive treatment with aripiprazole on body weight and clinical efficacy in schizophrenia patients treated with clozapine: a randomized, double-blind, placebo-controlled trial. Int J Neuropsychopharmacol. 2010;13(8):1115-1125.
-
(2010)
Int J Neuropsychopharmacol.
, vol.13
, Issue.8
, pp. 1115-1125
-
-
Fleischhacker, W.W.1
Heikkinen, M.E.2
Olié, J.P.3
-
14
-
-
0030615211
-
3 receptors and use of antipsychotics in patients with schizophrenia: A postmortem study
-
Gurevich EV, Bordelon Y, Shapiro RM, et al. Mesolimbic dopamine D3 receptors and use of antipsychotics in patients with schizophrenia: a postmortem study. Arch Gen Psychiatry. 1997;54(3): 225-232. (Pubitemid 27132051)
-
(1997)
Archives of General Psychiatry
, vol.54
, Issue.3
, pp. 225-232
-
-
Gurevich, E.V.1
Bordelon, Y.2
Shapiro, R.M.3
Arnold, S.E.4
Gur, R.E.5
Joyce, J.N.6
|